Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 75/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories has announced the allotment of 5,116 equity shares to employees as part of its Employee Stock Option Schemes. This allotment was approved by the Nomination, Governance, and Compensation Committee of the Board and will be effective on March 14, 2024. The shares have a par value of Rs. 5 per share and indicate the company's commitment to employee participation in its growth. The transaction details comply with SEBI regulations related to employee benefits and equity sharing.

Market Sentiment Analysis

POSITIVE FACTORS

  • Allotment of equity shares indicates company growth and employee engagement.
  • Stock options exercise demonstrates employee confidence in the company's future.
  • Increasing the equity base can enhance capital and financial stability.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Ltd. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Sub: Allotment of Equity Shares on exercise
of Stock Options under ESOPs
This is to inform you that the Nomination, Governance
and Compensation Committee of the Board of Directors of the Company has approved the allotment of 5,116 equity shares of Rs. 5/- each
of the Company, fully paid up, on March 14, 2024, to employees pursuant to exercise of their Stock Options, as per the following details:
Further, please find enclosed the details as required
under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR
Details under Regulation 10(c) of the SEBI
(Share Based Employee Benefits and Sweat Equity) Regulations, 2021
1 Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2 Name of the Stock Exchanges on which the company's shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy's Employees Stock Option Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: March 14, 2024 (Date of allotment on exercise)
9 Number of shares issued: 5,116 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 213215955 to 213221070
12 ISIN Number of the shares if issued in Demat: INE089A01023
13 Exercise price per share: (a) 1,826 equity shares exercised at Rs.5/- per share (b) 1,550 equity shares exercised at Rs.2,607/- per share (c) 1,740 equity shares exercised at Rs.3,679/- per share
14 Premium per share: (a) 1,826 equity shares- Nil (b) 1,550 equity shares - Rs. 2,602/- per share (c) 1,740 equity shares - Rs.3,674/- per share
15 Total Issued shares after this issue: 16,68,18,466 (*)
16 Total Issued share capital after this issue: Rs. 83,40,92,330 /-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA
(*) Total paid up capital after this issue: 166,818,266,
i.e., Rs. 834,091,330 (difference of 200 due to forfeited shares of Rs. 5/- each in September 1988 on account of non-payment of allotment

Frequently Asked Questions

What was the date of equity share allotment?

The equity shares were allotted on March 14, 2024.

How many equity shares were issued?

A total of 5,116 equity shares were issued.

What is the par value of the shares?

The par value of the shares is Rs. 5/- each.

Where are the shares listed?

The shares are listed on BSE, NSE, and NYSE.

Are the newly issued shares identical to existing shares?

Yes, the new shares rank pari passu with existing shares.

Last updated: Mar 15, 2024